Marbocyl SA

1 x 20 ml
Powder and solvent for suspension for injection
IV
SC

Active substance

  • Marbofloxacin : 200 mg
  • Species

    - DOGS

    - CATS

    Indications

    In dogs, Indicated:

    - in the treatment of infected wounds and subcutaneous abscesses due to Staphylococcus intermedius, Staphylococcus aureus, Escherichia coli, Pasteurella sp. and Pseudomonas sp.

    - in the treatment of lower or urinary tract infections due to Escherichia coli and Proteus sp.

    In cats, Indicated:

    - in the treatment of infected wounds and subcutaneous abscesses due to Pasteurella multocida, Staphylococcus intermedius, Staphylococcus aureus, Staphylococcus sp., Enterobacter sp. and Klebsiella sp. Marbofloxacin is inactive against anaerobic bacteria.

    Dose to be administered and administration route

    Reconstitution:- Before use, reconstitute the lyophilised powder using the solvent (water for injections) provided for the 200mg vial. Using aseptic technique withdraw 20ml from the vial of solvent and add rapidly to the lyophilised powder. When reconstituted in this way, the solution will contain 10mg marbofloxacin per ml.

    In dogs, the recommended doses and durations of treatment are:

    For the treatment of infected wounds and subcutaneous abscesses - a single subcutaneous or intravenous injection, at a dosage of 2mg/kg (1ml/5kg), followed the next day by administration of Marbocyl Tablets daily at a dosage of 2mg/kg for 6 days.


    For the treatment of lower urinary tract infections - a single subcutaneous or intravenous injection, at a dosage of 2mg/kg (1ml/5kg), followed the next day by administration of Marbocyl Tablets daily at 2mg/kg for at least 10 days and up to 28 days.


    In cats
    , the recommended doses and durations of treatment are:

    For the treatment of infected wounds and subcutaneous abscesses - 2 mg/kg/day (0.2ml/kg/day), by subcutaneous or intravenous injection followed by subcutaneous injections for a total of 3 to 5 days.

    Adverse reactions

    After subcutaneous administration, no undesirable effect is observed up to 2 times the maximum recommended therapeutic dose in dogs or 3 times the maximum recommended dose for cats.

    After i.v. administration at 4mg/kg, rare mild and transitory side effects have been reported:


    - ptyalism (excess salivation)

    - nervous disorders: vocalization, excitation, trembling (myoclonia).


    - Very rarely, hypersensitivity reactions, diarrhoea and vomiting have been reported


    - The frequency of adverse reactions is defined using the following convention:

    - - very rare (less than 1 animal in 10,000 animals treated, including isolated reports)

    EMA Categorisation

    B
    Cat
    Dog
    PRICE Only for registered vets. Create a free profile to access all features.. Login
    Art. Nr. 08007/4079
    EAN 3605874237575
    PACKAGES
    Marbocyl SA
    Vetoquinol
    1 x 20 ml
    08007/4079
    VETiSearch ApS - C.F. Richs Vej 99D - 2000 Copenhagen - Denmark - contact@vetisearch.co.uk - Legal registration number: 39926679
    VETiSearch.co.uk Copyright © 2025 . All rights reserved. This information is intended only for residents of Great Britain. The product information provided on this site is intended only for residents of Great Britain. Products may have different product information in different countries.